Cargando…
Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation
Altered cellular metabolism is now generally acknowledged as a hallmark of cancer cells, the resultant abnormal oncometabolites cause both metabolic and nonmetabolic dysregulation and potential transformation to malignancy. A subset of cancers have been found to be associated with mutations in succi...
Autores principales: | Mu, Xianmin, Zhao, Ting, Xu, Che, Shi, Wei, Geng, Biao, Shen, Jiajia, Zhang, Chen, Pan, Jinshun, Yang, Jing, Hu, Shi, Lv, Yuanfang, Wen, Hao, You, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355086/ https://www.ncbi.nlm.nih.gov/pubmed/28061458 http://dx.doi.org/10.18632/oncotarget.14485 |
Ejemplares similares
-
Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation
por: Aguiar, Carla J, et al.
Publicado: (2014) -
Clinical implications of the oncometabolite succinate in SDHx‐mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2019) -
The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy
por: Yang, Lei, et al.
Publicado: (2016) -
Succinate induces aberrant mitochondrial fission in cardiomyocytes through GPR91 signaling
por: Lu, Yi-Tong, et al.
Publicado: (2018) -
Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
por: Zhao, Yue, et al.
Publicado: (2020)